Financial Gravity Asset Management’s Enanta Pharmaceuticals ENTA Stock Holding History

Financial Gravity Asset Management’s Portfolio ENTA Stock Details ENTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$62K	Sell	21 -3	-13%	-$186	0.04%	527
2019 Q3	$1K	Sell	24 -6	-20%	-$446	﹤0.01%	1016
2019 Q2	$3K	Sell	30 -483	-94%	-$43.4K	﹤0.01%	792
2019 Q1	$49K	Buy	+513	New	+$46K	0.04%	320
2018 Q3	$4K	Buy	61 +13	+27%	+$1.3K	﹤0.01%	763
2018 Q2	$5K	Sell	48 -84	-64%	-$8.38K	﹤0.01%	741
2018 Q1	$13K	Buy	+132	New	+$10.2K	0.01%	548

Other funds holding ENTA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return

KAM

Krensavage Asset Management New York $263M AUM 66.99% 1-Year Est. Return

Financial Gravity Asset Management's ENTA Position: Q4 2019 in Review

Financial Gravity Asset Management reduced its Enanta Pharmaceuticals (ENTA) stake by 13% in Q4 2019, selling an estimated $186 and leaving 21 shares worth $62K. The position accounts for 0.04% of the portfolio, ranked #527.

Financial Gravity Asset Management first reported a position in ENTA in Q1 2018 and has held it in 7 quarters since. 171 funds tracked by Wall St. Rank hold ENTA as of Q4 2019.

Financial Gravity Asset Management held 21 shares of Enanta Pharmaceuticals worth $62K as of Q4 2019.
Financial Gravity Asset Management sold 3 Enanta Pharmaceuticals shares in Q4 2019, an estimated $186.
Enanta Pharmaceuticals made up 0.04% of Financial Gravity Asset Management's portfolio in Q4 2019, its #527 holding.
Financial Gravity Asset Management first reported a position in Enanta Pharmaceuticals in Q1 2018 and has held it in 7 quarters since.
171 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q4 2019.

Based on Financial Gravity Asset Management's 13F filing for Q4 2019, filed 28 Feb 2020.